- Home
- APRE vs CVR Comparison
APRE vs CVR Comparison
Compare APRE & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- CVR
- Stock Information
- Founded
- APRE 2006
- CVR 1920
- Country
- APRE United States
- CVR United States
- Employees
- APRE N/A
- CVR N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- CVR Industrial Machinery/Components
- Sector
- APRE Health Care
- CVR Industrials
- Exchange
- APRE Nasdaq
- CVR Nasdaq
- Market Cap
- APRE 9.7M
- CVR 11.1M
- IPO Year
- APRE 2019
- CVR N/A
- Fundamental
- Price
- APRE $1.75
- CVR $13.78
- Analyst Decision
- APRE Strong Buy
- CVR
- Analyst Count
- APRE 2
- CVR 0
- Target Price
- APRE $15.50
- CVR N/A
- AVG Volume (30 Days)
- APRE 35.7K
- CVR 2.8K
- Earning Date
- APRE 05-14-2025
- CVR 05-09-2025
- Dividend Yield
- APRE N/A
- CVR 0.87%
- EPS Growth
- APRE N/A
- CVR N/A
- EPS
- APRE N/A
- CVR N/A
- Revenue
- APRE $1,284,475.00
- CVR $26,379,081.00
- Revenue This Year
- APRE N/A
- CVR N/A
- Revenue Next Year
- APRE N/A
- CVR N/A
- P/E Ratio
- APRE N/A
- CVR N/A
- Revenue Growth
- APRE 33.27
- CVR N/A
- 52 Week Low
- APRE $1.41
- CVR $8.15
- 52 Week High
- APRE $5.01
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- APRE 49.51
- CVR 64.74
- Support Level
- APRE $1.60
- CVR $13.09
- Resistance Level
- APRE $2.00
- CVR $14.90
- Average True Range (ATR)
- APRE 0.16
- CVR 0.79
- MACD
- APRE 0.02
- CVR 0.23
- Stochastic Oscillator
- APRE 37.50
- CVR 71.50
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.